Utilization of the Eμ-Myc Mouse to Model Heterogeneity of Therapeutic Response

Human aggressive B-cell non-Hodgkin lymphomas (NHL) encompass the continuum between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), and display considerable clinical and biologic heterogeneity, most notably related to therapy response. We previously showed that lymphomas arising in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Autores principales: Rempel, Rachel E., Jiang, Xiaolei, Fullerton, Paul, Tan, Tuan Zea, Ye, Jieru, Lau, Jieying Amelia, Mori, Seiichi, Chi, Jen-Tsan, Nevins, Joseph R., Friedman, Daphne R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258467/
https://ncbi.nlm.nih.gov/pubmed/25349303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0044
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares